Hansa Biopharma publishes Annual Report 2020

By PRNewswire4 days ago

AD

LUND, Sweden, April 8, 2021 /PRNewswire/ -- Hansa Biopharma AB “Hansa“ (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announced the release of the Annual Report 2020

Sren Tulstrup, President and CEO of Hansa Biopharma, comments:

“2020 was a highly successful and transformative year for Hansa Biopharm - a year where we saw significant progress across all areas important to building a leading biopharmaceutical company: Pipeline development, medical and commercial operations and organizational development.

Continue read on benzinga.com